These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5655055)

  • 1. Plasma and urine levels of phenylbutazone in the horse.
    Piperno E; Ellis DJ; Getty SM; Brody TM
    J Am Vet Med Assoc; 1968 Jul; 153(2):195-8. PubMed ID: 5655055
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug interactions in the horse: effect of furosemide on plasma and urinary levels of phenylbutazone.
    Roberts BL; Blake JW; Tobin T
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):257-65. PubMed ID: 981785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of phenylbutazone preparations in the horse.
    Rose RJ; Kohnke JR; Baggot JD
    Equine Vet J; 1982 Jul; 14(3):234-7. PubMed ID: 7106088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronopharmacokinetics of phenylbutazone in the horse. Application to antidoping control].
    Jaussaud P; Courtot D; Doron P; Guyot JL
    Ann Rech Vet; 1985; 16(4):385-91. PubMed ID: 4091494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of phenylbutazone in competitions.
    Vogel C
    Vet Rec; 1981 Mar; 108(12):248. PubMed ID: 7269169
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on a new paste preparation of phenylbutazone.
    Snow DH; Douglas TA
    Vet Rec; 1983 Jun; 112(26):602-7. PubMed ID: 6879988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of feeding on the fate of orally administered phenylbutazone, trimethoprim and sulphadiazine in the horse.
    Bogan JA; Galbraith A; Baxter P; Ali NM; Marriner SE
    Vet Rec; 1984 Dec; 115(23):599-600. PubMed ID: 6523691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetics of anti-inflammatory drugs in serum and synovia of horses (author's transl)].
    Lehmann W; Wintzer HJ; Frey HH
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):218-20. PubMed ID: 7026207
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses.
    Lees P; Toutain PL
    Vet J; 2013 Jun; 196(3):294-303. PubMed ID: 23721873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting absorption of non-steroidal anti-inflammatory agents in the horse.
    Sullivan M; Snow DH
    Vet Rec; 1982 Jun; 110(24):554-8. PubMed ID: 7112870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.
    Gerken DF; Sams RA
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):467-76. PubMed ID: 3834064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uses and misuses of anti-inflammatory drus in racehorses. II.
    Moss MS
    Equine Vet J; 1972 Apr; 4(2):69-72. PubMed ID: 4677297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.